July 20, 2024

QXMédical is proud to announce that our Boosting Catheter, the premier guide extension designed for the treatment of complex Percutaneous Coronary Interventions (PCI) and Chronic Total Occlusions (CTOs), has achieved EU Medical Device Regulation (MDR) certification. This significant milestone underscores our unwavering commitment to quality and ensures the availability of our cutting-edge product to physicians and patients throughout Europe.

The EU MDR certification reflects the highest standards of safety and performance, affirming QXMédical's dedication to advancing medical technology and improving patient outcomes. This achievement would not have been possible without the exceptional dedication and expertise of our talented team at QXMédical. Their relentless pursuit of excellence has been instrumental in securing this certification.

"We are immensely proud of our team for their hard work and commitment to excellence," said Fernando Di Caprio, President at QXMédical. "This certification is a testament to our team's efforts and our continuous drive to innovate in the medical device industry. Together, we are making significant strides in improving patient care."

QXMédical remains committed to driving innovation in the treatment of PCI and CTOs, ensuring that our products meet the highest standards of quality and safety. We extend our heartfelt gratitude to everyone involved in this journey and look forward to continuing to make a positive impact on patient health and outcomes.

For further information, please contact us.

‍